We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New 'Protein Nano-Switch' Method Paves Way for Faster, More Accurate Diagnostic Tests

By LabMedica International staff writers
Posted on 02 Aug 2023

Presently, 'point of care' diagnostic tests that offer results on the spot, such as those for blood sugar, pregnancy, and COVID-19, utilize protein-sensing systems to detect sugar, pregnancy hormones, and COVID-19 proteins. More...

However, these tests make up only a small part of the requirements in a patient-centric healthcare model. The creation of new sensing systems is a demanding and lengthy task that involves significant trial and error. Researchers have now developed a new 'protein nano-switch' technique that significantly accelerates the development of similar diagnostic tests by reducing the required time and boosting success rates.

A multidisciplinary research team that included scientists from Queensland University of Technology (QUT, Brisbane, Australia) has developed an approach for designing molecular ON-OFF switches based on proteins that can be applied in numerous biotechnological, biomedical, and bioengineering settings. This innovative method which allows researchers to develop more rapid and accurate diagnostic tests involves using modified proteins to act like ON/OFF switches in response to specific targets. The key advantage is that the system is modular, much like building with Lego blocks, allowing for easy replacement of parts to target different elements—such as a different drug or a medical biomarker.

The new protein-engineering technology offers a unique way to create lab tests. It offers the potential to construct various diagnostic and analytic tests with a broad array of possible applications, including human and animal health diagnostics. The researchers demonstrated their technology by focusing on a cancer chemotherapy drug that is toxic and must be frequently measured to ensure patient safety. The sensor they designed for this drug uses a color change to identify and measure the drug. The next stage would involve testing the sensor for clinical use approval. The researchers intend to standardize and scale this approach and begin creating more complex subsystems. According to the researchers, there are two potential paths for future work.

"One is to develop computer models that allow us to design and build the switches even more rapidly and precisely," said Professor Kirill Alexandrov, of the QUT School of Biology and Environmental Science. "The other is to demonstrate the scale and potential of the technology by building many switches for different diagnostic applications."

Related Links:
QUT 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
8-Channel Pipette
SAPPHIRE 20–300 µL
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The tool enables scientists to track real-time fluctuations in T cell function with unprecedented speed and precision (Photo courtesy of Shutterstock)

Luminescent Probe Measures Immune Cell Activity in Real Time

The human immune system plays a vital role in defending against disease, but its activity must be precisely monitored to ensure effective treatment in cancer therapy, autoimmune disorders, and organ transplants.... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.